Conway Caroline, Graham Jennifer L, Chengot Preetha, Daly Catherine, Chalkley Rebecca, Ross Lisa, Droop Alastair, Rabbitts Pamela, Stead Lucy F
Precancer Genomics, Leeds Institute of Cancer and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, UK.
Stratified Medicine (Oncology), School of Biomedical Sciences, University of Ulster, Coleraine, Co. Londonderry, BT52 1SA, UK.
Oncotarget. 2015 Nov 24;6(37):40186-201. doi: 10.18632/oncotarget.5529.
Oral squamous cell carcinoma (OSCC) is a prevalent cancer with poor prognosis. Most OSCC progresses via a non-malignant stage called dysplasia. Effective treatment of dysplasia prior to potential malignant transformation is an unmet clinical need. To identify markers of early disease, we performed RNA sequencing of 19 matched HPV negative patient trios: normal oral mucosa, dysplasia and associated OSCC. We performed differential gene expression, principal component and correlated gene network analysis using these data. We found differences in the immune cell signatures present at different disease stages and were able to distinguish early events in pathogenesis, such as upregulation of many HOX genes, from later events, such as down-regulation of adherens junctions. We herein highlight novel coding and non-coding candidates for involvement in oral dysplasia development and malignant transformation, and speculate on how our findings may guide further translational research into the treatment of oral dysplasia.
口腔鳞状细胞癌(OSCC)是一种预后较差的常见癌症。大多数OSCC通过一个称为发育异常的非恶性阶段发展而来。在潜在恶性转化之前有效治疗发育异常是一项尚未满足的临床需求。为了识别早期疾病的标志物,我们对19对匹配的HPV阴性患者三联样本进行了RNA测序:正常口腔黏膜、发育异常和相关的OSCC。我们使用这些数据进行了差异基因表达、主成分和相关基因网络分析。我们发现不同疾病阶段存在的免疫细胞特征存在差异,并且能够区分发病机制中的早期事件,如许多HOX基因的上调,与后期事件,如黏附连接的下调。我们在此强调参与口腔发育异常发展和恶性转化的新的编码和非编码候选基因,并推测我们的发现如何指导进一步针对口腔发育异常治疗的转化研究。